Cargando…

T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia

SIMPLE SUMMARY: The treatment of chronic lymphocytic leukemia (CLL) is a rapidly evolving field; however, despite recent progress, CLL remains incurable. Different types of immunotherapy have emerged as therapeutic options for CLL, aiming to boost anti-tumor immune responses; that said, despite init...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlachonikola, Elisavet, Stamatopoulos, Kostas, Chatzidimitriou, Anastasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268526/ https://www.ncbi.nlm.nih.gov/pubmed/34209724 http://dx.doi.org/10.3390/cancers13133255

Ejemplares similares

T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
por: Vlachonikola, Elisavet, et al.
Publicado: (2021)

High-throughput analysis of the T-cell receptor gene repertoire in low-count monoclonal B-cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia
por: Agathangelidis, Andreas, et al.
Publicado: (2020)

Context-dependent T-cell Receptor Gene Repertoire Profiles in Proliferations of T Large Granular Lymphocytes
por: Assmann, Jorn L.J.C., et al.
Publicado: (2023)

T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations
por: Vlachonikola, Elisavet, et al.
Publicado: (2023)

T cells in chronic lymphocytic leukemia: can they fight?
por: Vardi, Anna, et al.
Publicado: (2017)

TRIP - T cell receptor/immunoglobulin profiler
por: Kotouza, Maria Th., et al.
Publicado: (2020)

Editorial: The promise of immunogenetics for precision oncology
por: Vlachonikola, Elisavet, et al.
Publicado: (2023)

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL
por: Agathangelidis, Andreas, et al.
Publicado: (2022)

Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
por: Davi, Frédéric, et al.
Publicado: (2020)

Infrequent “chronic lymphocytic leukemia-specific” immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis
por: Agathangelidis, Andreas, et al.
Publicado: (2021)

Immunoglobulin Gene Repertoire in Chronic Lymphocytic Leukemia: Insight into Antigen Selection and Microenvironmental Interactions
por: Kostareli, Efterpi, et al.
Publicado: (2012)

P835: IN SILICO PREDICTION REVEALS PUTATIVE T-CELL CLASS I/II NEOEPITOPES WITHIN THE CLONOTYPIC IMMUNOGLOBULIN HEAVY AND LIGHT CHAINS IN PATIENTS WITH MULTIPLE MYELOMA
por: Gkoliou, Glykeria, et al.
Publicado: (2023)

Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia
por: Gavriilidis, George I., et al.
Publicado: (2020)

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
por: Baliakas, Panagiotis, et al.
Publicado: (2022)

The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia
por: Laidou, Stamatia, et al.
Publicado: (2022)

Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia
por: Oder, Blaž, et al.
Publicado: (2023)

Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin
por: Gerousi, Marina, et al.
Publicado: (2021)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
por: Galigalidou, Chrysi, et al.
Publicado: (2021)

The Spectrum of Genetic Defects in Chronic Lymphocytic Leukemia
por: Rossi, Davide, et al.
Publicado: (2012)

Challenges and Solutions for Collecting and Analyzing Real World Data: The Eric CLL Database as an Illustrative Example
por: Chatzidimitriou, Anastasia, et al.
Publicado: (2020)

B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making
por: Gemenetzi, Katerina, et al.
Publicado: (2020)

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia
por: Papakonstantinou, Nikos, et al.
Publicado: (2016)

Assessing Patients’ Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece
por: Karamanidou, Christina, et al.
Publicado: (2021)

Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
por: Wang, Zong-Han, et al.
Publicado: (2023)

The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia
por: Gerousi, Marina, et al.
Publicado: (2021)

Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia
por: Polychronidou, Eleftheria, et al.
Publicado: (2018)

Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?
por: Langerak, Anton W., et al.
Publicado: (2020)

Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia
por: Pepe, Felice, et al.
Publicado: (2020)

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
por: Agathangelidis, Andreas, et al.
Publicado: (2018)

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2019)

P1360: CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE
por: Lysandrou, Memnon, et al.
Publicado: (2023)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Time to Retire?
por: Scarfò, Lydia, et al.
Publicado: (2019)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?
por: Danilov, Alexey V., et al.
Publicado: (2019)

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
por: Tsagiopoulou, Maria, et al.
Publicado: (2019)

Lenalidomide and Chronic Lymphocytic Leukemia
por: González-Rodríguez, Ana Pilar, et al.
Publicado: (2013)

Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects
por: Manukyan, Gayane, et al.
Publicado: (2017)

Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working Group
por: Sofou, Electra, et al.
Publicado: (2023)

Erratum to: Partial versus Productive Immunoglobulin Heavy Locus Rearrangements in Chronic Lymphocytic Leukemia: Implications for B-Cell Receptor Stereotypy
por: Tsakou, Eugenia, et al.
Publicado: (2013)

Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity
por: Sofou, Electra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6vdd10eektu1sl9av2kqqi3r1n